Prudential plc’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,616
Closed -$575K 912
2022
Q4
$575K Sell
2,616
-2,223
-46% -$408K 0.01% 723
2022
Q3
$652K Buy
4,839
+2,683
+124% +$461K 0.01% 506
2022
Q2
$349K Buy
+2,156
New +$337K 0.01% 652
2019
Q4
Sell
-14,937
Closed -$1.82M 784
2019
Q3
$1.82M Buy
+14,937
New +$1.98M 0.01% 491

Other funds holding ONC

Prudential plc's ONC Position: Q1 2023 in Review

Prudential plc sold out of BeOne Medicines Ltd (ONC) in Q1 2023, closing a stake of 2,616 shares — an estimated $575K sold.

Prudential plc first reported a position in ONC in Q3 2019 and held it in 4 quarters. The position peaked at $1.82M in Q3 2019. 220 funds tracked by Wall St. Rank hold ONC as of Q1 2023.

  • Prudential plc reported no remaining BeOne Medicines Ltd position as of Q1 2023 after selling out during the quarter.
  • Prudential plc sold 2,616 BeOne Medicines Ltd shares in Q1 2023, an estimated $575K.
  • Prudential plc first reported a position in BeOne Medicines Ltd in Q3 2019 and held it in 4 quarters.
  • Prudential plc's BeOne Medicines Ltd position peaked at $1.82M in Q3 2019.
  • 220 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2023.

Based on Prudential plc's 13F filing for Q1 2023, filed 12 May 2023.